Just logically looking at plausible timelines. Phase 3 is imminent- the Pfizer therapeutic phase 3 trial was halted early on positive results. Biotron will be well motivated to start phase 3 ASAP.
Don’t forget that the BIT-225 HIV trials are ongoing too. Biotron will sell the full kit or not at all. They will not dilute a potential value of BIT-225 with HIV by first forming a partnership where it would be used as a therapeutic for COVID. If Big Pharma wants in, they’ll have to pay for both.
MM will have a dollar value in mind. The moment that cheque is big enough, it will sell.
Biotron Share Price Competition Jan 1 2022, page-244
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.009(32.1%) |
Mkt cap ! $16.24M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.5¢ | 1.8¢ | $312.3K | 15.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2319324 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 397381 | 2 |
View Market Depth
| Last trade - 14.28pm 06/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |